바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Next
e-Submission

Vol.69 No.6
Citation Share

Asthma Year in Review

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2010, v.69 no.6, pp.411-417

(2010). Asthma Year in Review. Tuberculosis & Respiratory Diseases, 69(6), 411-417.
  • Downloaded
  • Viewed
PDF Download

Abstract

This review highlights articles pertaining to the following 5 topics: the relationship between asthma, allergic and non-allergic rhinitis; the novel asthma phenotypes using cluster analysis; the diagnostic properties of inhaled dry-powder mannitol for the diagnosis of asthma; the value of mepolizumab therapy in exacerbations of refractory eosinophilic asthma; the role of bronchial thermoplasty in the treatment of severe asthma.

keywords
Asthma, Rhinitis, Cluster analysis, Mannitol, mepolizumab, Asthma, Rhinitis, Cluster analysis, Mannitol, mepolizumab

Reference

1.

1. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049-57.

2.

2. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-334.

3.

3. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma.J Allergy Clin Immunol 2002;109:419-25.

4.

4. Plaschke PP, Janson C, Norrman E, Björnsson E, Ellbjär S, Järvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000;162:920-4.

5.

5. Leynaert B, Neukirch C, Kony S, Guénégou A, Bousquet J, Aubier M, et al. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol 2004;113:86-93.

6.

6. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H,Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.Am J Respir Crit Care Med 2010;181:315-23.

7.

7. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, et al. Characterization of the severe asthma phenotype by the National Heart,Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:405-13.

8.

8. Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Diagnostic properties of inhaled mannitol in the diagnosis of asthma: a population study. J Allergy Clin Immunol 2009;124:928-32.

9.

9. Brusasco V, Crimi E. Methacholine provocation test for diagnosis of allergic respiratory diseases. Allergy 2001;56:1114-20.

10.

10. de Meer G, Marks GB, Postma DS. Direct or indirect stimuli for bronchial challenge testing: what is the relevance for asthma epidemiology? Clin Exp Allergy 2004;34:9-16.

11.

11. Anderson SD. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine,and mannitol. Curr Opin Pulm Med 2008;14:39-45.

12.

12. Porsbjerg C, Brannan JD, Anderson SD, Backer V.Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation,peak flow variability and quality of life in asthma patients. Clin Exp Allergy 2008;38:43-50.

13.

13. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84.

14.

14. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000;161:64-72.

15.

15. Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 2005;115:720-7.

16.

16. Green RH, Brightling CE, McKenna S, Hargadon B,Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-21.

17.

17. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemière C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.Eur Respir J 2006;27:483-94.

18.

18. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD,Efthimiadis A, Pizzichini E, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.N Engl J Med 2009;360:985-93.

19.

19. Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade Lima M, Shah PL, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind,sham-controlled clinical trial. Am J Respir Crit Care Med 2010;181:116-24.

20.

20. Cox PG, Miller J, Mitzner W, Leff AR. Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations. Eur Respir J 2004;24:659-63.

21.

21. Danek CJ, Lombard CM, Dungworth DL, Cox PG, Miller JD, Biggs MJ, et al. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 2004;97:1946-53.

22.

22. Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA,Niven RM, et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007;176:1185-91.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy